ArticleMolecules (Basel, Switzerland)2025
Preparation and Characterization of Highland Barley Distillers' Grains Gliadin-Chitosan Nanoparticles and Composite Properties.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In embedding systems, protein-polysaccharide complexes can be utilized as wall materials to improve the bioavailability and activity of bioactive substances during delivery. This study used the antisolvent precipitation method to manufacture gliadin from highland barley distillers' grains (HBDGG)-chitosan (Cs) nanoparticles. Using a variety of characterization techniques, the microstructure and interaction mechanism of HBDGG-Cs nanoparticles were examined, and their stability was assessed. In comparison to HBDGG, the results indicated that the addition of Cs enhanced the intensity of UV absorption and reduced the intensity of fluorescence. The content of α-helix dropped, while β-sheet, β-turn, and irregularly coiled content rose in the complexes. Hydrogen bonding, hydrophobic interactions, and electrostatic interactions were the primary forces that formed the nanoparticles. The contact force between HBDGG and Cs enhanced the stability of the nanoparticles. The particle size, polydispersity index (PDI), and zeta potential were 526.10 ± 11.78 nm, 0.20 ± 0.06, and 51.31 ± 0.66 mV, respectively, at a mass ratio of 1:1 between HBDGG and Cs. The nanoparticles exhibited good ionic, acid-base, and storage stability in addition to being widely distributed. This work offers a theoretical foundation for employing HBDGG-Cs nanoparticles to deliver bioactive components in food as well as a novel method for the comprehensive usage of HBDGG and Cs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.